Comparing drug combinations for graft-versus-host disease prophylaxis using the U.S. Food and Drug Administration Adverse Event Reporting System
Background : Graft-versus-host disease (GVHD) is a severe complication for transplant patients, particularly those undergoing allogeneic hematopoietic stem cell transplantation. Although various GVHD prophylaxis drug combinations are administered in clinical settings, previous studies have primarily...
Saved in:
Main Authors: | Toru Ogura, Chihiro Shiraishi, Aiko Urawa |
---|---|
Format: | Article |
Language: | English |
Published: |
The Korean Society for Transplantation
2025-06-01
|
Series: | Clinical Transplantation and Research |
Subjects: | |
Online Access: | https://www.ctrjournal.org/journal/view.html?doi=10.4285/ctr.24.0049 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Extracorporeal photopheresis in the treatment of graft-versus-host disease
by: I. V. Guz, et al.
Published: (2016-03-01) -
The incidence and risk factors of chronic rejection in acutely rejected pediatric liver transplantation
by: S. M. Dehghani, et al.
Published: (2022-01-01) -
Decreased frequency and inflammatory change of FoxP3+ regulatory T cells in immunopathogenesis of human acute graft-versus-host disease
by: Nayeon Seong, et al.
Published: (2025-07-01) -
Efficacy and safety of ruxolitinib combined with steroids for first-line treatment of acute graft-versus-host disease after hematopoietic stem cell transplantation: a single-center, real-world experience
by: Yan Yang, et al.
Published: (2025-07-01) -
PHARMACOECONOMIC ANALYSIS OF DIFFERENT METHODS FOR THE TREATMENT OF STEROID-REFRACTORY GRAFT-VERUS-HOST DISEASE: SINGLE-CENTER STUDY
by: I. S. Moiseev, et al.
Published: (2018-03-01)